On May 26, IDIBELL and the National Center for Genome Analysis (CNAG) signed a collaboration agreement between the two institutions in order to promote and disseminate CNAG activity within the IDIBELL to facilitate their access to CNAG’s different resources available in the field of sequencing and genomic analysis. Through this agreement, the CNAG offers IDIBELL the material and human resources and potential, to establish collaborations in the field of genomics and others who can be identified, designed to: These partnerships will be implemented in different ways either by carrying out projects in the field of genomics or technical advice or consultancy by the CNAG, host of IDIBELL research staff at CNAG or participation consortium of two centers in projects competitive research, among others.
The CNAG is a nonprofit organization funded by the Spanish Ministry of Science and Innovation and the Catalan Government through the Department of Economy and Knowledge and the Department of Health. The CNAG was created in 2009 as a platform with a mission to carry out projects in DNA sequencing and analysis in collaboration with researchers from Catalonia, Spain and the international research community to ensure the competitiveness of our country in the strategic area genomics.
It was launched in March 2010 and currently has eleven teams next generation sequencing, sequencing with a capacity of more than 1000 GBases / day, equivalent to sequence human genomes completely new every 24 hours. This capability positions the CNAG as one of Europe’s leading centers in terms of sequencing capacity. It has a team of 65 highly qualified people. Bioinformatics team, along with their IT infrastructure places the CNAG as a center of excellence in data analysis.
The CNAG involved in projects of genome sequencing and analysis in fields as diverse as cancer genetics, rare diseases, host-pathogen interactions, the preservation of endangered species, evolutionary studies and the improvement of the species of agricultural interest in collaboration with scientists from universities, hospitals, research centers and companies in the biotechnology and pharmaceutical industry